BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 20421523)

  • 1. Nuclear receptor Nurr1 is expressed in and is associated with human restenosis and inhibits vascular lesion formation in mice involving inhibition of smooth muscle cell proliferation and inflammation.
    Bonta PI; Pols TW; van Tiel CM; Vos M; Arkenbout EK; Rohlena J; Koch KT; de Maat MP; Tanck MW; de Winter RJ; Pannekoek H; Biessen EA; Bot I; de Vries CJ
    Circulation; 2010 May; 121(18):2023-32. PubMed ID: 20421523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of nuclear receptor Nur77 by 6-mercaptopurine protects against neointima formation.
    Pires NM; Pols TW; de Vries MR; van Tiel CM; Bonta PI; Vos M; Arkenbout EK; Pannekoek H; Jukema JW; Quax PH; de Vries CJ
    Circulation; 2007 Jan; 115(4):493-500. PubMed ID: 17242285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p27kip1-838C>A single nucleotide polymorphism is associated with restenosis risk after coronary stenting and modulates p27kip1 promoter activity.
    van Tiel CM; Bonta PI; Rittersma SZ; Beijk MA; Bradley EJ; Klous AM; Koch KT; Baas F; Jukema JW; Pons D; Sampietro ML; Pannekoek H; de Winter RJ; de Vries CJ
    Circulation; 2009 Aug; 120(8):669-76. PubMed ID: 19667240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of angio-associated migratory cell protein inhibits smooth muscle cell migration and neointima formation in accelerated atherosclerosis.
    Vogt F; Zernecke A; Beckner M; Krott N; Bosserhoff AK; Hoffmann R; Zandvoort MA; Jahnke T; Kelm M; Weber C; Blindt R
    J Am Coll Cardiol; 2008 Jul; 52(4):302-11. PubMed ID: 18634987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease-activated receptor-1 antagonist F 16618 reduces arterial restenosis by down-regulation of tumor necrosis factor α and matrix metalloproteinase 7 expression, migration, and proliferation of vascular smooth muscle cells.
    Chieng-Yane P; Bocquet A; Létienne R; Bourbon T; Sablayrolles S; Perez M; Hatem SN; Lompré AM; Le Grand B; David-Dufilho M
    J Pharmacol Exp Ther; 2011 Mar; 336(3):643-51. PubMed ID: 21139058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in the pig coronary artery injury model: comparison of plain old balloon angioplasty and stent implantation].
    Shimizu N; Suzuki H; Wakabayashi K; Iso Y; Shibata M; Yorozuya M; Katagiri T; Takeyama Y
    J Cardiol; 2004 Mar; 43(3):131-9. PubMed ID: 15067801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.
    Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C
    Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combined treatment with angiotensin II type 1 receptor blocker and statin on stent restenosis.
    Yoshikawa M; Nakamura K; Nagase S; Sakuragi S; Kusano KF; Matsubara H; Ohe T
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):179-86. PubMed ID: 19188828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced connexin43 expression limits neointima formation after balloon distension injury in hypercholesterolemic mice.
    Chadjichristos CE; Matter CM; Roth I; Sutter E; Pelli G; Lüscher TF; Chanson M; Kwak BR
    Circulation; 2006 Jun; 113(24):2835-43. PubMed ID: 16769907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cascade model for restenosis. A special case of atherosclerosis progression.
    Libby P; Schwartz D; Brogi E; Tanaka H; Clinton SK
    Circulation; 1992 Dec; 86(6 Suppl):III47-52. PubMed ID: 1424051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of the cell-cycle inhibitors p27(Kip1) and p21(Cip1) in human atherectomy specimens: primary stenosis versus restenosis.
    Braun-Dullaeus RC; Ziegler A; Bohle RM; Bauer E; Hein S; Tillmanns H; Haberbosch W
    J Lab Clin Med; 2003 Mar; 141(3):179-89. PubMed ID: 12624599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stent-based local delivery of nuclear factor-kappaB decoy attenuates in-stent restenosis in hypercholesterolemic rabbits.
    Ohtani K; Egashira K; Nakano K; Zhao G; Funakoshi K; Ihara Y; Kimura S; Tominaga R; Morishita R; Sunagawa K
    Circulation; 2006 Dec; 114(25):2773-9. PubMed ID: 17130346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-derived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo.
    Hacker TA; Griffin MO; Guttormsen B; Stoker S; Wolff MR
    J Invasive Cardiol; 2007 Jun; 19(6):269-74. PubMed ID: 17541129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanisms of re-stenosis after angioplasty].
    Bauriedel G; Kandolf R; Welsch U; Höfling B
    Z Kardiol; 1994; 83 Suppl 4():31-41. PubMed ID: 7856278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remnant lipoprotein-induced smooth muscle cell proliferation involves epidermal growth factor receptor transactivation.
    Kawakami A; Tanaka A; Chiba T; Nakajima K; Shimokado K; Yoshida M
    Circulation; 2003 Nov; 108(21):2679-88. PubMed ID: 14623816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The intron 6 G/T polymorphism of c-myb oncogene and the risk for coronary in-stent restenosis.
    Gross CM; Krämer J; Pfeufer A; Dietz R; Gessner R; Praus M
    Basic Res Cardiol; 2004 Jul; 99(4):309-14. PubMed ID: 15221349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutated p21/WAF/CIP transgene overexpression reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice.
    Condorelli G; Aycock JK; Frati G; Napoli C
    FASEB J; 2001 Oct; 15(12):2162-70. PubMed ID: 11641242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferation of human primary vascular smooth muscle cells depends on serum response factor.
    Werth D; Grassi G; Konjer N; Dapas B; Farra R; Giansante C; Kandolf R; Guarnieri G; Nordheim A; Heidenreich O
    Eur J Cell Biol; 2010; 89(2-3):216-24. PubMed ID: 20096952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin stent coating does not reduce neointimal proliferation after coronary stenting.
    Scheller B; Schmitt A; Böhm M; Nickenig G
    Z Kardiol; 2003 Dec; 92(12):1025-8. PubMed ID: 14663613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased p53 gene dosage reduces neointimal thickening induced by mechanical injury but has no effect on native atherosclerosis.
    Sanz-González SM; Barquín L; García-Cao I; Roque M; González JM; Fuster JJ; Castells MT; Flores JM; Serrano M; Andrés V
    Cardiovasc Res; 2007 Sep; 75(4):803-12. PubMed ID: 17570351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.